Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Cytek BioSciences Inc
Swot
Cytek BioSciences Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Cytek BioSciences Inc has 13 Strengths, 11 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(13)
Weakness
(11)
Opportunity
(2)
Threats
(1)
Others
(1)
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock gained more than 20% in one month
Stock with Low PE (PE < = 10)
RSI indicating price strength
Stocks with Quarter Change % less than Industry
Momentum Trap (DVM)
Await Turnaround (DVM)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Highest fall from 52 Week High
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Profit to Loss Companies
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mutual Funds Decreased Shareholding in Past Month
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
